← Eichor
Condition: Anti Synthetase Syndrome Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anti Synthetase Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With
Phase 1 · 14 location(s) · Allogene Therapeutics · NCT07085104RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic I
Phase 2/Phase 3 · 35 location(s) · Cabaletta Bio · NCT06154252Environmental Risk Factors for the Anti-synthetase Syndrome
Phase N/A · 8 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT01276470MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Phase N/A · 1 location(s) · Myositis International Health & Research Collaborative Allia · NCT07374107
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.